Integra Lifesciences Holdings Corp reports results for the quarter ended in December - Earnings Summary

Integra LifeSciences Holdings

22/02/2023 14:32

* Integra Lifesciences Holdings Corp  IART.OQ  reported
quarterly
adjusted earnings of 94 cents​​ per share for the quarter ended
in December. The mean expectation of twelve analysts for the
quarter was for earnings of 90 cents per share.
    * Revenue fell 1.8% to $398.02 million from a year ago;
analysts
expected $397.95 million. 
    * Integra Lifesciences Holdings Corp's reported EPS for the
quarter was 63 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.4%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Integra Lifesciences Holdings Corp shares had risen
by 1.1% this
quarter.
    * The company reported quarterly net income of $52.95
million.
    * Wall Street's median 12-month price target for Integra
Lifesciences Holdings Corp is $58.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 9
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
22 at 02:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.90           0.94           Beat
 Sep. 30 2022      0.72           0.86           Beat
 Jun. 30 2022      0.80           0.81           Beat
 Mar. 31 2022      0.68           0.74           Beat